Table 1.
Baseline patient characteristics
| Patient | Age | Gleason score | Pretherapy PSA | Risk category | RT dose | RT target | Foley (F) or straight cath (SC) dependent | Baseline IPSS | Baseline CPSI | Baseline QoL | Baseline prostate volume (cm3) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PN 1 | 83 | 4 + 4 = 8 | 25.1 | High | 8100 cGy/45 fx | Prostate and SV | F | N/A∗ | N/A∗ | N/A∗ | 31.6 |
| PN 2 | 69 | 3 + 4 = 7 | 6.35 | Intermediate | 7020 cGy/26 fx | Prostate and SV | N | 26 | N/A | 5 | 52 |
| PN 3 | 75 | 4 + 3 = 7 | 2.2 | Intermediate | N/A† | Prostate and SV | N | 7 | 6 | 2 | 74 |
| PN 4 | 66 | 3 + 4 = 7 | 20.8 | High | 7800 cGy/39 fx | Prostate and SV | N | 4 | N/A | 6 | 65 |
| PN 5 | 69 | 3 + 3 = 6 | 3.9 | Low | 8100 cGy/45 fx | Prostate and SV | N | 23 | 19 | 5 | 22 |
| PN 6 | 85 | 4 + 4 = 8 | 9.7 | High | HDR‡ + 4500 cGy/25 fx |
Prostate and SV | N | 23 | 20 | 3 | 44 |
| PN 7 | 61 | 4 + 5 = 9 | 6.4 | High | 4500 cGy/25 fx (prostate) 3600 cGy/20 fx (pelvis and SV) |
Prostate, SV, and sacrum | N | N/A | 34 | 6 | 46 |
| PN 8 | 72 | 3 + 4 = 7 | 5.7 | Low-intermediate | 7020 cGy/26 fx | Prostate and SV | SC | N/A | 25 | 4 | 122.9 |
| PN 9 | 77 | 4 + 5 = 9 | 6.86 | High | 7920 cGy/44 fx | Prostate and SV | N | N/A | 30 | 5 | 25 |
Abbreviations: CPSI = Chronic Prostatitis Symptom Index; IPSS = International Prostate Symptom Score; N = no catheterization; PSA = prostate-specific antigen; QoL = quality of life; RT = radiation therapy; SV = seminal vesicles.
∗
On Foley catheter.
†
Retention after 3 treatments of RT, so patient stopped.
‡
Referred from outside institution, high dose rate dose unknown.